(111 days)
No
The device description and performance studies focus on the material properties, mechanical testing, and sterilization of a ceramic hip prosthesis component. There is no mention of AI or ML in the provided text.
Yes
The device is a component of a hip prosthesis system, used to treat various degenerative joint diseases and fractures, which are conditions that impair normal body function or structure, thereby qualifying it as a therapeutic device.
No
The device is a component of a hip prosthesis system used for replacement surgery to address various hip conditions, not for diagnosing them.
No
The device is a ceramic head component of a hip prosthesis system, which is a physical implant, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the Bencox Forte and Bencox Delta ceramic heads are for use in total or partial hip arthroplasty. This is a surgical procedure involving the replacement of a joint, not a diagnostic test performed on samples taken from the body.
- Device Description: The device is described as a component of a Hip Prosthesis System intended for mechanical fixation to a hip stem and articulation within a hip joint. This is a medical device used within the body for structural support and function, not for analyzing biological samples.
- Lack of IVD Characteristics: The description does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Detecting or measuring substances in biological samples
- Providing information for diagnosis, monitoring, or screening of diseases or conditions
The device is a surgical implant used in orthopedic surgery.
N/A
Intended Use / Indications for Use
The Bencox Forte and Bencox Delta ceramic heads is intended for use in total or partial hip arthroplasty in primary or revision surgery for the following conditions: a. Non-inflammatory degenerative joint disease, such as avascular necrosis, osteoarthritis, traumatic arthritis b. Inflammatory degenerative joint disease, such as rheumatoid arthritis c. Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques d. Patients with failed previous surgery where pain, deformity, or dysfunction persists e. Revision of previously failed hip arthroplasty.
Product codes
LZO
Device Description
The Bencox Biolox Ceramic Head is a component of a Hip Prosthesis System and intended for mechanical fixation to a mating hip stem, with a standard 12/14 taper. It is intended to articulate between both Highly Cross Linked UHMWPE as well as Conventional UHMWPE.
The Bencox Ceramic Head is available as standard type and is manufactured from bio-inert alumina ceramic, Al2O3 as per ASTM F603 / ISO 6474. The ceramic femoral balls heads range in diameter from 28 mm to 40 mm with small, medium & large versions.
Radiation (gamma) sterilization is used for Bencox Forte and Bencox Delta Biolox ceramic heads. Sterilization by Co-60 gamma irradiation has been validated to a sterility assurance level (SAL) of 10-6 by the bioburden method, according to ISO 11137-1 & ISO 11137-2. Following sterilization packaging was validated for a shelf life of 5 years for BENCOX Forte & Delta ceramic femoral heads.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance testing of the Bencox Forte/Delta Femoral Heads was conducted in accordance with the international standards. All required testing per "Guidance Document for the Preparation of Premarket Notifications of Ceramic Ball Hip Systems" were performed.
- Component testing of BIOLOX forte ball head 28-12/14 L on titanium test tapers per CeramTec AG test procedure VA 02 04 4129, ISO 7206-10.
- Influence of diameter and neck length on burst strength of BIOLOX forte and BIOLOX delta ball heads with taper type 12/14. Burst test setup as per ISO 7206-10.
- Sterilization validation as per ISO 11137 1 & 2 Sterilization of health care products - Radiation.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3353 Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis.
(a)
Identification. A hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis is a device intended to be implanted to replace a hip joint. This device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. The two-part femoral component consists of a femoral stem made of alloys to be fixed in the intramedullary canal of the femur by impaction with or without use of bone cement. The proximal end of the femoral stem is tapered with a surface that ensures positive locking with the spherical ceramic (aluminium oxide, A12 03 ) head of the femoral component. The acetabular component is made of ultra-high molecular weight polyethylene or ultra-high molecular weight polyethylene reinforced with nonporous metal alloys, and used with or without bone cement.(b)
Classification. Class II.
0
K121665 (pg 1/3)
510(K) SUMMARY
EP 25 2012
Corentec Co., Ltd.
BENCOX® Forte & BENCOX® Delta
4th June, 2012
ADMINISTRATIVE INFORMATION
| Manufacturer | Corentec Co., Ltd. |
|---|---|
| 247 Giro-ri, Ipjang-myeon, Seobuk-Gu | |
| Cheonan-si, Chungchongnam-do, 331-822 South Korea | |
| Telephone: +82-41-585-7114 | |
| Fax: +82-41-585-7113 | |
| Official Contact | J.S. Daniel |
| Project Manager - RA/QA | |
| Corentec Co., Ltd | |
| 11th Chungho Tower, 748-1 Banpo 1 Dong | |
| Seocho Gu, Seoul, Korea 137-040 | |
| Ph: +82 2 3445 5492 | |
| Fax: +82 2 3445 5497 |
Email: jsdaniel@corentec.com
DEVICE NAME AND CLASSIFICATION
| Trade/Proprietary Name: | Bencox Forte & Bencox Delta |
|---|---|
| Common Name: | Femoral Head Prosthesis |
| Classification Regulations: | 21 CFR 888.3353 |
| Class | II |
| Product Codes: | LZO |
| Classification Panel: | Orthopedic Products Panel |
| Reviewing Branch: | Orthopedic Devices Branch |
INTENDED USE
The Bencox Forte and Bencox Delta ceramic heads is intended for use in total or partial hip arthroplasty in primary or revision surgery for the following conditions: a. Non-inflammatory degenerative joint disease, such as avascular necrosis, osteoarthritis, traumatic arthritis
b. Inflammatory degenerative joint disease, such as rheumatoid arthritis
1
c. Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques d. Patients with failed previous surgery where pain, deformity, or dysfunction persists e. Revision of previously failed hip arthroplasty
DEVICE DESCRIPTION
The Bencox Biolox Ceramic Head is a component of a Hip Prosthesis System and intended for mechanical fixation to a mating hip stem, with a standard 12/14 taper. It is intended to articulate between both Highly Cross Linked UHMWPE as well as Conventional UHMWPE.
The Bencox Ceramic Head is available as standard type and is manufactured from bio-inert alumina ceramic, Al2O3 as per ASTM F603 / ISO 6474. The ceramic femoral balls heads range in diameter from 28 mm to 40 mm with small, medium & large versions.
Radiation (gamma) sterilization is used for Bencox Forte and Bencox Delta Biolox ceramic heads. Sterilization by Co-60 gamma irradiation has been validated to a sterility assurance level (SAL) of 10-6 by the bioburden method, according to ISO 11137-1 & ISO 11137-2. Following sterilization packaging was validated for a shelf life of 5 years for BENCOX Forte & Delta ceramic femoral heads.
SUBSTANTIAL EQUIVALENCE TO MARKETED DEVICES
BENCOX Forte & BENCOX Delta Biolox components are substantially equivalent in indications and design principles to the predicate devices, each of which has been determined by FDA to be substantially equivalent:
- MEDACTA International SA; MectaCer BIOLOX forte Femoral Heads cleared . under K073337,
- DePuy Orthopedics, Inc., DePuy Delta Ceramic Femoral Head cleared under . K062748,
- Corentec Co., Ltd., Coren Total Hip System & Bencox Bipolar Cup System . cleared under K103431 & K112019 (Femoral Heads).
PERFORMANCE TESTING
Performance testing of the Bencox Forte/Delta Femoral Heads was conducted in accordance with the international standards. All required testing per "Guidance Document for the Preparation of Premarket Notifications of Ceramic Ball Hip Systems" were performed.
2
- Component testing of BIOLOX forte ball head 28-12/14 L on titanium test tapers . per CeramTec AG test procedure VA 02 04 4129, ISO 7206-10.
- Influence of diameter and neck length on burst strength of BIOLOX forte and . BIOLOX delta ball heads with taper type 12/14. Burst test setup as per ISO 7206-10.
- Sterilization validation as per ISO 11137 1 & 2 Sterilization of health care . products - Radiation.
Any differences in technological characteristic between the subject and predicate devices do not raise new issues of safety or efficacy of the BENCOX Forte & BENCOX Delta Biolox components for its intended use.
Overail, the BENCOX Forte & BENCOX Delta Biolox components have the following similarities to the predicate devices:
- has the same intended use, .
- uses the same operating principles, .
- incorporates the same basic designs, .
- incorporates the same or similar materials, and ●
- has similar packaging and sterilized using the same materials and processes. .
3
Image /page/3/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of an eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
SEP 25 2012
Corentec Co., Ltd. Seoul Office % J.S. Daniel· Project Manager - RA/QA 11th Chungho Tower 748-1 Banpo 1 Dong Seocho Gu, Seoul Republic of Korea 137-040
Re: K121665
Trade/Device Name: BENCOX® Forte & BENCOX® Delta Regulation Number: 21 CFR 888.3353 Regulation Name: Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis Regulatory Class: Class II
Product Code: LZO Dated: August 28, 2012 Received: August 30, 2012
Dear Mr. Daniel
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Mr. J.S. Daniel
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
INDICATIONS FOR USE
510(k) Number (if known):
Device Name: BENCOX Forte & BENCOX Delta
The Bencox Forte and Bencox Delta ceramic heads are intended for use in total or partial hip arthroplasty in primary or revision surgery for the following conditions:
- a) Non-inflammatory degenerative joint disease, such as avascular necrosis, osteoarthritis, traumatic arthritis
- b) Inflammatory degenerative joint disease, such as rheumatoid arthritis
- c) Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques
- d) Patients with failed previous surgery where pain, deformity, or dysfunction persists
- e) Revision of previously failed hip arthroplasty.
Prescription Use: X _ (Per 21 CFR 801 Subpart D) AND / OR
Over-The Counter Use: (Per 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE -CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
A. Suls.
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
×121665 510(k) Number
Corentec Co. Ltd